Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
The Food and Drug Administration approved the VisuMax Femtosecond Laser for use in a surgical procedure to reduce or eliminate myopia — nearsightedness — in patients.
The Food and Drug Administration recently approved Shire's new drug Cuvitru to treat patients with primary immunodeficiency diseases.
Pfizer recently submitted trial data to the Food and Drug Administration for Chantix — a drug intended to help its users quit smoking — in the hopes the agency would remove a serious warning from the drug's label. Instead, the…
Dallas-based Hillwood Development will sell its distribution center portfolio to Global Logistics Properties for $1.1 billion, according to The Wall Street Journal.
Rapid City, S.D.-based Regional Health earned the Ascend Peak Performance Award for exceptional clinical and supply chain performance.
The Indiana Blood Center reached a critically low supply of O-negative blood on Monday, causing the center to send out an urgent call for donations, reported the Tribune Star.
A new study shows supply chain executives demonstrate higher levels of psychopathic tendencies than any other role in the business world, reports the AustralianFinancial Review.
Lake Forest, Ill.-based Horizon Pharma will reportedly buy La Jolla, Calif.-based Raptor Pharmaceutical for $800 million, according to Reuters.
Veniti, the developer of a patented venous stent system, has secured $25 million in funding from Boston Scientific Corp. The company will use the investment to complete a trial and regulatory filing for its stent system as well as grow…
San Diego-based Obalon Therapeutics earned Food and Drug Administration approval for its Obalon Balloon System, a nonsurgical weight loss device for patients who failed to lose weight through diet and exercise.